| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 300 | 263 | 374 | 963 | | Cost of Revenue | 35 | 4 | 20 | 11 | | | Gross Profit | 265 | 259 | 355 | 953 | | | Operating Expenses | | Research Development | 649 | 1,062 | 822 | 753 | | Selling General and Administrative | 806 | 575 | 915 | 792 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,190) | (1,378) | (1,382) | (592) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5 | 34 | 7 | 12 | | Earnings Before Interest And Taxes | (1,186) | (1,344) | (1,375) | (581) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,186) | (1,344) | (1,375) | (581) | | Income Tax Expense |
-
|
-
|
-
| (15) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,186) | (1,344) | (1,375) | (566) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,186) | (1,344) | (1,375) | (566) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,186) | ($1,344) | ($1,375) | ($566) |
|
0.51% Nasdaq 
Income Statement
